Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valenta Pharm is a prominent Russian pharmaceutical company dedicated to the development, manufacturing, and commercialization of high-quality innovative and generic medicines. The company maintains a diverse portfolio across several key therapeutic areas, including virology, psychoneurology, gastroenterology, immunology, and reproductive health. Valenta Pharm is well-known for its flagship products such as Ingavirin, an antiviral for respiratory infections, and Phenazepam, a widely used anxiolytic. Operating a large-scale, high-tech production facility in Shchyolkovo that adheres to international GMP standards, the company is a major supplier to both the retail pharmacy sector and hospital markets in Russia and the CIS region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valenta Medical.